
3D Cell Culture
Notice: You have been redirected
You have been redirected to a different store based on your location.
Visit your local store
It looks like you are visiting from another country. Would you like to switch to your local store for a better experience?
Checkout using your account
This form is protected by reCAPTCHA - the Google Privacy Policy and Terms of Service apply.
Checkout as a new customer
Creating an account has many benefits:
Extracellular vesicles (EVs), including exosomes, play a crucial role in tumor biology. Alongside modulating the tumor microenvironment and contributing to the malignant cascade (angiogenesis, the host immune system response, and metastasis), EVs are involved in chemoresistance. Docetaxel in prostate cancer, for example, may transport mRNA encoding drug-resistant proteins or carry miRNA to recipient cells and trigger the expression of specific target genes.
These functions make them an excellent target for the development of novel types of cancer treatment, including:
Figure 1: The role of EVs in tumor biology and possibilities of treatment for cancer.
Despite their essential role in tumor biology and promise as therapeutic agents, the identification and production of EVs offer different challenges that have yet to be overcome:
First vesicle-free growth media to harvest EVs from cancer cell lines
As EVs are secreted from cancer cells, the endosomal/cellular process of EV production depends on cell growth. Thereby, it is vital to support the cell growth without changing cell behaviors and characteristics to optimize the exosome yield.
The problem already starts when choosing an appropriate medium that is, on the one hand, free of EVs and, on the other hand, sufficiently supports the cell growth. Serum-free, chemically defined media or media from which the vesicles have been removed often lack sufficient nutrients or cell growth factors to warrant a proper cell culture over several days or weeks. Furthermore, these media can induce cell stress and impair the EV yield.
We have developed a toolbox of serum- and xeno-free media for cancer cultures, which support healthy growth and improved expansion of cells over many weeks. Additionally, the media can be used for cells from all different sources, offering the great benefit that only one medium can be used for different cancer cell cultures.
The advantage for your EV production:
The Cancer Cell Line Medium XF is a vesicle-free medium (< 1% compared to FCS containing conventional media). As part of our cancer media toolbox, it is a synthetic medium, but in contrast to many chemical-defined media or vesicle-depleted media, it is a fully-fledged growth medium to enable long-term cultivation and multiple passaging.
Figure 2: The Cancer Cell Line Medium XF provides better cell growth performance compared to conventional serum-containing media. Left: The Cancer Cell Line Medium XF improves the growth performance of cancer cells compared to a conventional FCS-substituted medium. Right: The cell characteristics and morphology are maintained in the Cancer Cell Line Medium XF (upper right) compared to the serum-containing medium (lower right).
Efficiently harvest EVs from patient-specific cancer cell cultures
EVs can be isolated directly from the body from a variety of biological fluids including plasma, urine, semen, or tears. However, the complex composition of these fluids, such as metabolites, proteins or macro molecules, disturb the identification and analysis of cancer-specific EVs. Additionally, investigating cancer-derived EVs and identifying new cancer biomarkers requires cancer cell-specific EVs. EVs must subsequently be isolated from pure cancer cell cultures in a vesicle-free environment.
We have developed a cancer media toolbox for the efficient isolation and expansion of patient-derived cancer cells, including tumor-initiating cancer stem cells. These are synthetic media that can be used individually or in combination to select pure CSCs or CSCs together with further differentiated cancer cells while preserving the characteristics of the cancer cells.
Using our cancer media, you can isolate EVs from pure patient-specific cancer cells as a reference to the EV-isolation from liquid biopsies.
Figure 3: Workflow to harvest EVs directly from patient-specific cancer cells
Patient-derived cancer cells can also serve as a great tool to investigate EV-mediated cell-cell and cell-matrix interactions.
If you want to learn how to establish your own patient-derived 2D and 3D models including CSC, cancer cells and non-cancer cells such as immune cells and fibroblasts you can find an overview on our website From Biopsy to Assay Development.
EVs are increasingly pivotal instruments for drug delivery, drug development and diagnostics. Therefore, the demand for media is increasing, especially for those which can be used in a clinical setting and which are GMP-compliant.
We are a trusted and certified manufacturer of cell culture media compliant to GMP regulatory requirements. This ensures the access to documentation required for your risk assessment to use our innovative media for clinical applications.
A complete defined and animal-component free cell culture solution designed for the selective culture of malignant cells derived from primary tumors or patient-derived xenografts.
NCCD Reagent is part of our Primary Cancer Culture System and is crucial for the pre-treatment of the culture vessel.
Serum-free and xeno-free medium for the standardized in vitro cultivation of established cancer cell lines. Fibronectin or vitronectin coating required.
Serum-free and xeno-free medium for the cultivation of cancer cell lines as 3D tumorspheres.
How do cancer stem cells develop? What is their role in tumor biology? What are current approaches to target cancer stem cells? And what are innovative solutions for working with them? Find all the answers...
As the potential for using mesenchymal stem cells in cancer therapy grows, understanding the biology behind them can help inform and inspire innovative cancer therapies. Using high quality media and culture...
Many scientists working in oncology focus on cancer stem cells (CSCs). Targeting these cells specifically could improve cancer therapy significantly. Because CSCs rely heavily on their environment, three-dimensional...
From bench to bedside and back: This is the direction of malignant mesothelioma research. Yet to understand the biology of this particular type of cancer, more basic insights are still needed. And translating...